| Detected | Trial | Change |
|---|---|---|
| 2026-06-09 | NCT07320521 A Study to Assess the Mass Balance of [14C]HRS-8080 in Healthy Chinese Postmenopausal… |
overall status: "Not Yet Recruiting" → "Completed" |
| 2026-06-09 | NCT07320521 A Study to Assess the Mass Balance of [14C]HRS-8080 in Healthy Chinese Postmenopausal… |
date change Primary completion moved earlier: 2026-03 -> 2026-01-28 |
| 2026-06-09 | NCT07320521 A Study to Assess the Mass Balance of [14C]HRS-8080 in Healthy Chinese Postmenopausal… |
date change Completion moved earlier: 2026-03 -> 2026-01-28 |
| 2026-06-06 | NCT07528027 Phase III Study of HRS-7535 for Hypertension With Overweight or Obesity |
Recruitment opened |
| 2026-06-03 | NCT07229950 A Phase 2 Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of… |
Enrollment reduced: 66 -> 48 participants |
| 2026-05-29 | NCT07589569 An Open-label, Multicenter, Phase II Clinical Study to Evaluate HRS-7058 in Patients With… |
Recruitment opened |
| 2026-05-23 | NCT07349069 A Phase III Trial Comparing HRS-8080 With Standard Endocrine Therapy in Patients With… |
Enrollment increased: 4800 -> 5500 participants |
| 2026-05-14 | NCT07322016 A Study of HRS-1301 Tablets in Healthy Subjects and Those With Impaired Kidney Function |
Recruitment opened |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-10 | NCT07639905 A Clinical Study Comparing the Bioavailability of HRS-2189 Tablets | Phase 1 | Not Yet Recruiting |
| 2026-06-04 | NCT07625774 Renal Efficacy and Safety of the Novel Oral Small-Molecule GLP-1RA HRS-7535 Evaluated in… | Phase 3 | Not Yet Recruiting |
| 2026-05-27 | NCT07608705 A Study to Assess the Effect of HRS-1301 on the Pharmacokinetics of Midazolam and… | Phase 1 | Not Yet Recruiting |
| 2026-05-22 | NCT07601048 A Trial of HRS-7058 in Advanced or Metastatic Non-Small Cell Lung Cancer Patients Who… | Phase 3 | Not Yet Recruiting |
| 2026-05-22 | NCT07601087 A Clinical Study of HRS-7156 in Healthy Participants | Phase 1 | Not Yet Recruiting |
| 2026-05-15 | NCT07589569 An Open-label, Multicenter, Phase II Clinical Study to Evaluate HRS-7058 in Patients With… | Phase 2 | Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT07024173 | A Phase 3 Study of HRS-8080 Versus Treatment Chosen by Physicians in Locally Advanced and… | Locally Advanced Breast Cancer | Recruiting |
| NCT07419828 | A Phase III Clinical Study on the Efficacy and Safety of HRS-1780 in the Treatment of… | Chronic Kidney Disease | Recruiting |
| NCT07349069 | A Phase III Trial Comparing HRS-8080 With Standard Endocrine Therapy in Patients With… | Breast Cancer | Recruiting |
| NCT07354022 | A Study to Evluate Efficacy and Safety of HRS-8080 Combined With Dalpiciclib in Patients… | Locally Advanced or Metastatic Breast Cancer | Recruiting |
| NCT07528027 | Phase III Study of HRS-7535 for Hypertension With Overweight or Obesity | Hypertension With Overweight or Obesity | Recruiting |
| NCT07601048 | A Trial of HRS-7058 in Advanced or Metastatic Non-Small Cell Lung Cancer Patients Who… | KRAS G12C-positive Advanced or Metastatic Non-Small Cell Lung Cancer Patients Who Have Failed Standard Treatment | Not Yet Recruiting |
| NCT07625774 | Renal Efficacy and Safety of the Novel Oral Small-Molecule GLP-1RA HRS-7535 Evaluated in… | Chronic Kidney Disease | Not Yet Recruiting |
| Phase 2 | |||
| NCT06820099 | Study on the Efficacy and Safety of HRS-7535 in Patients With Mild Decrease in Ejection… | Adults With Heart Failure, Mild Decrease in Ejection Fraction/Preserved Ejection Fraction, and Obesity | Recruiting |
| NCT06915142 | A Phase II Clinical Study of HRS-7058 in Combination With Antitumor Drugs in Patients… | Advanced Malignant Tumour | Recruiting |
| NCT07032077 | A Clinical Trial of HRS-7058 Combined Anti-tumor Drugs in Subjects With Solid Tumors | Solid Tumors | Recruiting |
| NCT07470983 | A Phase II Clinical Study on the Efficacy and Safety of HRS-1780 in Participants With… | Primary Aldosteronism | Recruiting |
| NCT07269717 | A Phase II Clinical Trial of HRS-1893 in the Treatment of Heart Failure With Preserved… | Heart Failure With Preserved Ejection Fraction | Recruiting |
| NCT07229950 | A Phase 2 Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of… | Adult Patients With Moderately to Severely Active Ulcerative Colitis | Recruiting |
| NCT07589569 | An Open-label, Multicenter, Phase II Clinical Study to Evaluate HRS-7058 in Patients With… | Pancreatic Cancer | Recruiting |
| Phase 1/2 | |||
| NCT06167694 | Clinical Study of HRS-8080 in Combination With Dalpiciclib Isethionate Tablets in… | Unresectable or Metastatic Breast Cancer | Recruiting |
| NCT06679036 | A Trial of HRS-2189 in Combination With Fluvastatin±HRS-6209, or HRS-8080±HRS-6209, or… | Advanced Unresectable or Metastatic Breast Cancer | Recruiting |
| NCT07389733 | A Study of HRS-6208 in Combination With HRS-8080, or Fulvestrant, or Letrozole, With or… | Advanced Unresectable or Metastatic Breast Cancer of Adults | Recruiting |
| NCT06922357 | A Phase I/II of HRS-6719 in Patients With Advanced/Metastatic Solid Tumors | Advanced/Metastatic Solid Tumors | Recruiting |
| Phase 1 | |||
| NCT06383871 | A Phase I Clinical Study of HRS-7058 in Patients With Advanced Malignant Tumour | Advanced Malignant Tumour | Recruiting |
| NCT07351968 | A Phase Ib Study to Evaluate the Efficacy and Safety of HRS-2129 in Patients With Knee… | Moderate Pain in Knee Osteoarthritis | Recruiting |
| NCT06770569 | A Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HRS-3802… | Advanced Solid Tumors | Recruiting |
| NCT07377721 | A Study of HRS-2129 in Patients With Diabetic Peripheral Neuropathic Pain | Diabetic Peripheral Neuropathic Pain | Recruiting |
| NCT07479641 | A Bioequivalence Study of Two Formulations of HRS-1893 Tablets in Healthy Participants | Cardiomyopathy | Recruiting |
| NCT07322016 | A Study of HRS-1301 Tablets in Healthy Subjects and Those With Impaired Kidney Function | Hyperlipidemias | Recruiting |
| NCT07557407 | A Mass Balance Study of [14C]HRS-1780 in Healthy Adult Male Subjects | Chronic Kidney Diseases | Not Yet Recruiting |